株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

超崩壊剤の世界市場 - 2023年までの予測:加工でんぷん、加工セルロース、クロスポビドン、イオン交換樹脂

Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 359268
出版日 ページ情報 英文 183 Pages
即納可能
価格
本日の銀行送金レート: 1USD=112.99円で換算しております。
Back to Top
超崩壊剤の世界市場 - 2023年までの予測:加工でんぷん、加工セルロース、クロスポビドン、イオン交換樹脂 Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) - Global Forecast to 2023
出版日: 2018年08月30日 ページ情報: 英文 183 Pages
概要

超崩壊剤市場は、2018年の3億6640万米ドルから、2023年までに5億3650万米ドルまで拡大すると見られています。市場は、2018年〜2023年のCAGR (複合年間成長率) で、7.9%の成長が予測されています。

当レポートでは、世界の超崩壊剤市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

 FIGURE 12 SUPERDISINTEGRANTS MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 超崩壊剤市場の概要
  • 超崩壊剤市場:地域別の成長機会
  • 地域構成:超崩壊剤市場
  • 合成超崩壊剤市場:種類・地域別
  • 超崩壊剤市場:先進市場 vs. 途上市場

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 機会
    • 課題

第6章 規制分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域

第7章 超崩壊剤の世界市場:種類別

  • イントロダクション
  • 合成超崩壊剤
    • クロスポビドン
    • 加工でんぷん (デンプングリコール酸ナトリウム)
    • 加工セルロース
    • ケイ酸カルシウム
    • イオン交換樹脂
  • 天然超崩壊剤
  • その他

第8章 超崩壊剤の世界市場:剤形別

  • イントロダクション
  • 錠剤
  • カプセル

第9章 超崩壊剤の世界市場:治療分野別

  • イントロダクション
  • 神経疾患
  • 消化器疾患
  • 腫瘍
  • 炎症性疾患
  • 感染症
  • 心血管疾患
  • 血液疾患

第10章 超崩壊剤の世界市場:地域別

  • イントロダクション
  • 欧州
  • 北米
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 競合状況と動向
  • 市場シェア分析

第12章 企業プロファイル

  • BASF SE
  • ASHLAND GLOBAL HOLDINGS INC.
  • DOWDUPONT INC.
  • ROQUETTE FRERES
  • DFE PHARMA
  • JRS PHARMA
  • 旭化成
  • MERCK KGAA
  • COREL PHARMA CHEM
  • AVANTOR PERFORMANCE MATERIALS, LLC

第13章 付録

図表

LIST OF TABLES

  • TABLE 1: INCREASE IN GERIATRIC POPULATION ACROSS THE GLOBE
  • TABLE 2: DRUGS FACING PATENT EXPIRY
  • TABLE 3: KEY MARKET DRIVERS: IMPACT ANALYSIS
  • TABLE 4: KEY MARKET OPPORTUNITIES: IMPACT ANALYSIS
  • TABLE 5: KEY MARKET CHALLENGES: IMPACT ANALYSIS
  • TABLE 6: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 7: SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 8: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 9: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 10: CROSPOVIDONE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 11: MODIFIED STARCH SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 12: MODIFIED CELLULOSE SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 13: MODIFIED CELLULOSE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 14: CROSCARMELLOSE SODIUM SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 15: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 16: CALCIUM SILICATES SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 17: ION EXCHANGE RESINS SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 18: NATURAL SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 19: OTHER SUPERDISINTEGRANTS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 20: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 21: SUPERDISINTEGRANTS MARKET FOR TABLETS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 22: SUPERDISINTEGRANTS MARKET FOR CAPSULES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 24: SUPERDISINTEGRANTS MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 25: SUPERDISINTEGRANTS MARKET FOR GASTROINTESTINAL DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 26: SUPERDISINTEGRANTS MARKET FOR ONCOLOGY, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 27: SUPERDISINTEGRANTS MARKET FOR INFLAMMATORY DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 28: SUPERDISINTEGRANTS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 29: SUPERDISINTEGRANTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 30: SUPERDISINTEGRANTS MARKET FOR HEMATOLOGICAL DISEASES, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 31: SUPERDISINTEGRANTS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 32: EUROPE: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: EUROPE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 34: EUROPE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 35: EUROPE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 36: EUROPE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 37: EUROPE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 38: SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: SWITZERLAND: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 40: SWITZERLAND: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 41: SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 42: SWITZERLAND: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 43: GERMANY: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 44: GERMANY: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 45: GERMANY: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 46: GERMANY: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 47: GERMANY: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 48: ITALY: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 49: ITALY: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 50: ITALY: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 51: ITALY: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 52: ITALY: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 53: FRANCE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 54: FRANCE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 55: FRANCE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 56: FRANCE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 57: FRANCE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 58: UK: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 59: UK: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 60: UK: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 61: UK: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 62: UK: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 63: SPAIN: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 64: SPAIN: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 65: SPAIN: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 66: SPAIN: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 67: SPAIN: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 68: ROE: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 69: ROE: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 70: ROE: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 71: ROE: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 72: ROE: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 73: NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 74: NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: NORTH AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: NORTH AMERICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 78: NORTH AMERICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 79: US: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: US: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: US: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 82: US: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 83: US: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 84: CANADA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 85: CANADA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: CANADA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 87: CANADA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 88: CANADA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 89: ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 90: ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: ASIA PACIFIC: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 92: ASIA PACIFIC: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 94: ASIA PACIFIC: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 95: JAPAN: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 96: JAPAN: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 97: JAPAN: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: JAPAN: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 99: JAPAN: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 100: CHINA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: CHINA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: CHINA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: CHINA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 104: CHINA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 105: INDIA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 106: INDIA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 107: INDIA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: INDIA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 109: INDIA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 110: ROAPAC: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: ROAPAC: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: ROAPAC: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 113: ROAPAC: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 114: ROAPAC: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 115: LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: LATIN AMERICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: LATIN AMERICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 119: LATIN AMERICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 120: MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: MIDDLE EAST & AFRICA: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 122: MIDDLE EAST & AFRICA: MODIFIED CELLULOSE MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 123: MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2016-2023 (USD MILLION)
  • TABLE 124: MIDDLE EAST & AFRICA: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1: SUPERDISINTEGRANTS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATIONS, AND REGION
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: SUPERDISINTEGRANTS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: SUPERDISINTEGRANTS MARKET, BY FORMULATION, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA, 2018 VS. 2023 (USD MILLION)
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT: SUPERDISINTEGRANTS MARKET
  • FIGURE 12: INCREASING ADOPTION OF ORALLY DISINTEGRATING TABLETS IS EXPECTED TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: US DOMINATED THE GLOBAL SUPERDISINTEGRANTS MARKET IN 2017
  • FIGURE 14: APAC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 15: CROSPOVIDONE ACCOUNTED FOR THE LARGEST SHARE OF THE GLOBAL SUPERDISINTEGRANTS MARKET IN 2017
  • FIGURE 16: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE BETWEEN 2018 & 2023
  • FIGURE 17: SUPERDISINTEGRANTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: SYNTHETIC SUPERDISINTEGRANTS TO DOMINATE THE GLOBAL SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 19: TABLETS SEGMENT TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 20: NEUROLOGICAL DISEASES TO DOMINATE THE SUPERDISINTEGRANTS MARKET DURING 2018-2023
  • FIGURE 21: CANCER INCIDENCE ACROSS KEY COUNTRIES, 2012
  • FIGURE 22: ANNUAL NUMBER OF DEATHS DUE TO INFECTIOUS DISEASES, 2016
  • FIGURE 23: SUPERDISINTEGRANTS MARKET: GEOGRAPHIC SNAPSHOT (2017)
  • FIGURE 24: EUROPE: PHARMACEUTICAL PRODUCTION, 2015 (USD MILLION)
  • FIGURE 25: EUROPE: GENERICS MARKET (2014)
  • FIGURE 26: EUROPE: SUPERDISINTEGRANTS MARKET SNAPSHOT
  • FIGURE 27: NORTH AMERICA: SUPERDISINTEGRANTS MARKET SNAPSHOT
  • FIGURE 28: ASIA PACIFIC: SUPERDISINTEGRANTS MARKET SNAPSHOT
  • FIGURE 29: KEY DEVELOPMENTS IN THE SUPERDISINTEGRANTS MARKET FROM 2015 TO MAY 2018
  • FIGURE 30: SUPERDISINTEGRANTS MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 31: BASF SE: COMPANY SNAPSHOT (2017)
  • FIGURE 32: ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 33: DOWDUPONT INC.: COMPANY SNAPSHOT (2017)
  • FIGURE 34: ROQUETTE FRERES: COMPANY SNAPSHOT (2017)
  • FIGURE 35: ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 36: MERCK KGAA: COMPANY SNAPSHOT (2017)
  • FIGURE 37: MARKETSANDMARKETS KNOWLEDGE STORE: HEALTHCARE INDUSTRY SNAPSHOT
目次
Product Code: PH 4350

"The global superdisintegrants market is projected to grow at a CAGR of 7.9%."

The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants. The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.

"The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period."

By type, the superdisintegrants market is segmented into natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. The synthetic superdisintegrants segment is further subsegmented into modified starch, cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, ion exchange resins, and calcium silicates. The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the widespread use of these superdisintegrants in various oral drug formulations, especially in orally disintegrating tablets.

"Tablet formulation segment is expected to witness the highest growth during the forecast period."

By formulation, the superdisintegrants market is segmented into tablets and capsules. The tablets segment is expected to witness the highest CAGR owing to the widespread use of orally disintegrating tablets (ODT) and fast-disintegrating tablets among healthcare providers and patients driven by the advantages such as increasing drug bioavailability, better pregastric absorption, ease of swallowing in patients with dysphagia, ease of administration, and improved shelf life.

"APAC superdisintegrants market is projected to witness the highest growth during the forecast period."

Europe held the largest share of the global superdisintegrants market in 2017. On the other hand, the APAC superdisintegrants market is expected to witness the highest CAGR during the forecast period, owing to the significant growth in pharmaceutical manufacturing in the past few years, low-cost manufacturing advantage, increasing per capita income, low regulatory stringency, and growing interest of key players in APAC countries.

Break of primary participants was as mentioned below:

  • By Company Type: Tier 1-48%, Tier 2-34% and Tier 3-18%
  • By Designation: C-level-42%, Director Level-40%, Others-18%
  • By Region: North America-38%, Europe-32%, Asia Pacific-21%, Latin America-6%, Middle East & Africa-3%

The prominent players in the global superdisintegrants market are: Ashland Inc. (US), BASF SE (Germany), DowDuPont (US), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), Asahi Kasei Corporation (Japan), Merck KGaA (Germany), Corel Pharma Chem (India), and Avantor Performance Materials, LLC (US).

Research Coverage:

The report analyzes the various superdisintegrants products and their adoption pattern. It aims at estimating the market size and future growth potential of the global superdisintegrants market for different segments by type, formulation, therapeutic area, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global superdisintegrants market
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global superdisintegrants market
  • Market Development: Comprehensive information on the lucrative and emerging market
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global superdisintegrants market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global superdisintegrants market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. STAKEHOLDERS
  • 1.6. LIMITATIONS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
    • 2.1.1. SECONDARY RESEARCH
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY RESEARCH
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Break down of primaries
      • 2.1.2.3. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. DATA TRIANGULATION APPROACH
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. SUPERDISINTEGRANTS MARKET OVERVIEW
  • 4.2. SUPERDISINTEGRANTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.3. REGIONAL MIX: SUPERDISINTEGRANTS MARKET (2018-2023)
  • 4.4. SYNTHETIC SUPERDISINTEGRANTS MARKET, BY TYPE AND REGION (2017)
  • 4.5. SUPERDISINTEGRANTS MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2018 VS 2023

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. MARKET DRIVERS
      • 5.2.1.1. Growing adoption of orally disintegrating tablets
      • 5.2.1.2. Growing generics market
      • 5.2.1.3. Emergence of new superdisintegrants for the pharmaceutical industry
    • 5.2.2. MARKET OPPORTUNITIES
      • 5.2.2.1. Pharmaceutical market expansion in emerging countries
    • 5.2.3. MARKET CHALLENGES
      • 5.2.3.1. Safety and quality concerns

6. REGULATORY ANALYSIS

  • 6.1. INTRODUCTION
  • 6.2. NORTH AMERICA
    • 6.2.1. US
    • 6.2.2. CANADA
  • 6.3. EUROPE
  • 6.4. ASIA PACIFIC
    • 6.4.1. JAPAN
    • 6.4.2. CHINA
    • 6.4.3. INDIA

7. SUPERDISINTEGRANTS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. SYNTHETIC SUPERDISINTEGRANTS
    • 7.2.1. CROSPOVIDONE
    • 7.2.2. MODIFIED STARCH (SODIUM STARCH GLYCOLATE)
    • 7.2.3. MODIFIED CELLULOSE
      • 7.2.3.1. Croscarmellose sodium
      • 7.2.3.2. Low-substituted hydroxypropyl cellulose
    • 7.2.4. CALCIUM SILICATES
    • 7.2.5. ION EXCHANGE RESINS
  • 7.3. NATURAL SUPERDISINTEGRANTS
  • 7.4. OTHER SUPERDISINTEGRANTS

8. SUPERDISINTEGRANTS MARKET, BY FORMULATION

  • 8.1. INTRODUCTION
  • 8.2. TABLETS
  • 8.3. CAPSULES

9. SUPERDISINTEGRANTS MARKET, BY THERAPEUTIC AREA

  • 9.1. INTRODUCTION
  • 9.2. NEUROLOGICAL DISEASES
  • 9.3. GASTROINTESTINAL DISEASES
  • 9.4. ONCOLOGY
  • 9.5. INFLAMMATORY DISEASES
  • 9.6. INFECTIOUS DISEASES
  • 9.7. CARDIOVASCULAR DISEASES
  • 9.8. HEMATOLOGICAL DISEASES

10. SUPERDISINTEGRANTS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. EUROPE
    • 10.2.1. SWITZERLAND
    • 10.2.2. GERMANY
    • 10.2.3. ITALY
    • 10.2.4. FRANCE
    • 10.2.5. UK
    • 10.2.6. SPAIN
    • 10.2.7. REST OF EUROPE
  • 10.3. NORTH AMERICA
    • 10.3.1. US
    • 10.3.2. CANADA
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA PACIFIC
  • 10.5. LATIN AMERICA
  • 10.6. MIDDLE EAST & AFRICA

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. COMPETITIVE SITUATION AND TRENDS
  • 11.3. MARKET SHARE ANALYSIS

12. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)f

  • 12.1. BASF SE
  • 12.2. ASHLAND GLOBAL HOLDINGS INC.
  • 12.3. DOWDUPONT INC.
  • 12.4. ROQUETTE FRERES
  • 12.5. DFE PHARMA
  • 12.6. JRS PHARMA
  • 12.7. ASAHI KASEI CORPORATION
  • 12.8. MERCK KGAA
  • 12.9. COREL PHARMA CHEM
  • 12.10. AVANTOR PERFORMANCE MATERIALS, LLC

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS
  • 13.6. AUTHOR DETAILS
Back to Top